Alzheimer's disease
Drinkable cocktail shows promise interfering with crucial step of Alzheimer’s
January 08 by Natasha TaylorYale researchers have identified a drinkable cocktail of designer molecules to target the damaging prion protein interactions with amyloid beta
IMS Disease Insights – Alzheimer’s disease: Primary research & evidence-based data
November 11 by Pharmaceuticals & Biotechnology EditorOf the nine major pharmaceutical markets (i.e., US, UK, France, Germany, Italy, Spain, Japan, China, Brazil), IMS Health forecasts that the Alzheimer’s disease market will grow from $5.7 billion in 20...
Disease Patterns and Demographics Affecting Asia
December 03 by Pharma IQAsia's vast size, socioeconomic disparities and rapidly changing demographics continually present new challenges to healthcare providers. Ageing populations within China and Japan mean the ne...
Market for CNS Biomarkers Predicted to Grow to $3.2 Billion by 2015
December 02 by Pharma IQBiomarkers are now being used by a large number of companies in the biopharmaceutical industry - and one of the key therapeutic areas where they are utilised is in CNS drug development, wher...